How NMDP BioTherapies is Transforming Cellular Therapy in Transplant Centers
On-demand panel discussion link
Description
NMDPSM BioTherapies®—what's that? In this session, learn how NMDP is supporting cell therapy in transplant centers today and into the future.
Learning Objectives
- Developments in the cell and gene therapy field and how that will impact transplant centers
- How the NMDP is extending its expertise to support clinical trials in transplant centers and across the cell and gene therapy industry
- How the NMDP can help advocate for your teams as more cell therapies move into the clinic and become commercially available
- Review challenges and opportunities in onboarding and working on clinical trials in transplant centers
Target Audience
Coordinators, physicians, medical directors
Speakers
- Joy Aho, PhD, Serior Product Manager, NMDP
- Jeffery Auletta, MD, SVP, Patient Outcomes & Experience, NMDP & Chief Scientific Director, CIBMTR® (Center for International Blood and Marrow Transplant Research®)
- Makensie Becker, Client Success Manager, NMDP BioTherapies
- Eric Davis, MPH, CHTC, Program Manager, BMT Unrelated Donor Search Program, Memorial Sloan Kettering
- Jamey Hardesty, MPH, Clinical Operations Partner, NMDP